Athira Pharma's total assets for Q1 2025 were $43.51M, a decrease of -25.97% from the previous quarter. ATHA total liabilities were $6.18M for the fiscal quarter, a -55.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.